The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (5 analysts) rates it none, with a mean price target of $7.
Banco Santander (Brasil) SA ADR
BSBR · the NYSE · USD · Market cap $44.1B · 49,107 employees
Banco Santander (Brasil) S.A., together with its subsidiaries, provides various banking products and services to individuals, small and medium enterprises, and corporate customers in Brazil and internationally.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Banco Santander (Brasil) SA ADR holds its Accumulation at $5.89. The statistical read favours the buyers, held for 6 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the buyers, held for 6 days |
| Price at the screen | $5.89 |
| Valuation | 16.83 trailing · 6.87 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.18 |
Five Screens, Shown in Full
Does not pass. Excluded industry: Banks - Regional
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Excluded industry: Banks - Regional | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 37.5% margin of safety to the base estimate.
Third-party analyst targets: 3 covering, consensus None. The average target sits +22% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCheap Brazilian bank fails our ethical screen
Picture a Sao Paulo shopkeeper taking a loan or a firm wiring funds across borders and Santander Brasil sits in the middle of every transaction. We are staying away, not because the numbers look broken but because the ethical screen rules out regional banks outright. That single filter overrides everything else on the table.
The stock trades at 5.5 times forward earnings with 28 percent profit margins and a narrow moat, yet revenue growth sits at zero and return on equity is only 10 percent. Analysts call it a hold with a seven dollar median target against the five twenty four price, but none of that moves the needle once the industry screen is failed.
The real risk is the permanent exclusion plus exposure to Brazil's cycles and thin returns on equity. This is exactly what the screen is for. Analysis, not advice.
| Forward P/E | 6.9xcheap for a company growing this fast |
| Trailing P/E | 16.8xreasonably valued |
| EPS, trailing | 0.35 |
| EPS, forward | 0.86 |
| Revenue growth | +28.8%strong top-line growth |
| Profit margin | 28.7%healthy profit margins |
| Return on equity | 11.2%a modest return on shareholder capital |
| Dividend yield | 628.00% |
| Beta | 0.18barely tracks the market's swings |
| 52-week range | 4.94 - 7.32 |
| Moat | NARROW |
| Market cap | $44.1B |
| Employees | 49,107 |
The risks · The things to watch: its business and earnings are exposed to Brazil and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBSBR trades on the NYSE (the company is based in Brazil). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (5 analysts) rates it none, with a mean price target of $7.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (5 analysts) rates it none, with a mean price target of $7.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Banco Santander Brasil SA ADR (BSBR) Looks to Score Double With AI Insider Monkey · 6 May 2026
- Banco Santander Brasil Q1 Earnings Call Highlights MarketBeat · 30 Apr 2026
- BSBR vs. UOVEY: Which Stock Should Value Investors Buy Now? Zacks · 23 Apr 2026
- Banco Santander Brasil (BSBR) Hits BRL 4.1B Q4 Net Income with 17.6% ROE Insider Monkey · 8 Mar 2026
- Banco Santander-Brazil (BSBR) Upgraded to Buy: What Does It Mean for the Stock? Zacks · 10 Feb 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $5.70 | -7.3% | · | $927 | -7.3% |
| 2 months | $6.30 | -16.1% | $0.11 | $856 | -14.4% |
| 3 months | $5.71 | -7.4% | $0.11 | $944 | -5.6% |
| 6 months | $5.83 | -9.3% | $0.11 | $925 | -7.5% |
| 1 year | $5.01 | +5.5% | $0.20 | $1,095 | +9.5% |
| 2 years | $4.61 | +14.6% | $0.48 | $1,250 | +25.0% |
| 3 years | $5.45 | -3.1% | $0.81 | $1,117 | +11.7% |
| 5 years | $6.27 | -15.7% | $1.73 | $1,118 | +11.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BSBR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.